CGMS | PHK | CGMS / PHK | |
Gain YTD | 2.205 | 3.393 | 65% |
Net Assets | 2.72B | 793M | 343% |
Total Expense Ratio | 0.39 | 1.07 | 36% |
Turnover | 39.00 | 29.00 | 134% |
Yield | 5.72 | 11.06 | 52% |
Fund Existence | 3 years | 22 years | - |
CGMS | PHK | |
---|---|---|
RSI ODDS (%) | 2 days ago31% | N/A |
Stochastic ODDS (%) | 2 days ago29% | 2 days ago71% |
Momentum ODDS (%) | 2 days ago74% | 2 days ago88% |
MACD ODDS (%) | 2 days ago68% | 2 days ago69% |
TrendWeek ODDS (%) | 2 days ago70% | 2 days ago83% |
TrendMonth ODDS (%) | 2 days ago67% | 2 days ago82% |
Advances ODDS (%) | 3 days ago68% | 4 days ago84% |
Declines ODDS (%) | 17 days ago41% | 10 days ago75% |
BollingerBands ODDS (%) | 2 days ago42% | N/A |
Aroon ODDS (%) | 2 days ago59% | 2 days ago83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QCLGX | 25.53 | N/A | N/A |
Federated Hermes MDT Large Cap Growth C | |||
JVSAX | 14.28 | N/A | N/A |
Janus Henderson Small-Mid Cap Value A | |||
BSMKX | 16.31 | N/A | N/A |
iShares Russell Small/Mid-Cap Idx K | |||
RPTIX | 98.64 | N/A | N/A |
T. Rowe Price Mid-Cap Growth I | |||
GSBEX | 15.44 | N/A | N/A |
Goldman Sachs Small Cap Growth R6 |
A.I.dvisor tells us that CGMS and DBD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGMS and DBD's prices will move in lockstep.
Ticker / NAME | Correlation To CGMS | 1D Price Change % | ||
---|---|---|---|---|
CGMS | 100% | -0.18% | ||
DBD - CGMS | 22% Poorly correlated | +0.59% | ||
NFE - CGMS | 15% Poorly correlated | -4.03% |